Literature DB >> 2020192

Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway.

J E Albina1, W L Henry.   

Abstract

The amino acid L-arginine can be metabolized through a nitric oxide-synthesizing pathway (NOSP) to produce L-citrulline and reactive nitrogen intermediates. Among these nitrogen intermediates, NO has been implicated as the mediator of a variety of biological effects including vasodilatation, inhibition of platelet aggregation, tumor cytotoxicity and microbiostasis by activated macrophages and generalized suppression of macrophage functions. Work reported here demonstrated that the NOSP is expressed in Con A-stimulated rat splenic cell (SC) cultures and is associated with a profound suppression of lymphocyte proliferation. Inhibition of the NOSP by NG-monomethyl-L-arginine (N-MMA) or binding of its products by hemoglobin, either free in solution or contained in RBC, markedly promotes rat SC mitogenic response to Con A. Mouse SC do not express the NOSP under the conditions used in these experiments. Consequently, their mitogenic response to Con A is not affected by N-MMA or hemoglobin. These data confirm and expand the apparent role of NO as a regulator of immune responses while indicating potentially important species differences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020192     DOI: 10.1016/0022-4804(91)90210-d

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  17 in total

1.  Activation of cationic amino acid transport through system y+ correlates with expression of the T-cell early antigen gene in human lymphocytes.

Authors:  C A Boyd; D H Crawford
Journal:  Pflugers Arch       Date:  1992-10       Impact factor: 3.657

2.  Characterization of NR10(2) macrophages.

Authors:  J G Bruno; J E Parker; J Kalns; T J Darcy; T R Grubbs; A B Cox; P J Morales; J L Alls; J L Kiel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-09       Impact factor: 2.416

3.  Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition.

Authors:  Jennifer L Szczytkowski; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

4.  Avian reovirus induces an inhibitory effect on lymphoproliferation in chickens.

Authors:  S Neelima; G C Ram; J M Kataria; T K Goswami
Journal:  Vet Res Commun       Date:  2003-01       Impact factor: 2.459

5.  Molecular and metabolic evidence for the restricted expression of inducible nitric oxide synthase in healing wounds.

Authors:  J S Reichner; A J Meszaros; C A Louis; W L Henry; B Mastrofrancesco; B A Martin; J E Albina
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

6.  Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.

Authors:  Andrew L Doedens; Christian Stockmann; Mark P Rubinstein; Debbie Liao; Na Zhang; David G DeNardo; Lisa M Coussens; Michael Karin; Ananda W Goldrath; Randall S Johnson
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

7.  Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages.

Authors:  C Pellat-Deceunynck; J Wietzerbin; J C Drapier
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

8.  Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages.

Authors:  T Kawabe; K I Isobe; Y Hasegawa; I Nakashima; K Shimokata
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus.

Authors:  Jennifer L Szczytkowski; Christina Lebonville; Lee Hutson; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2013-01-26       Impact factor: 7.217

10.  Macrophages produce nitric oxide at allograft sites.

Authors:  J M Langrehr; D A White; R A Hoffman; R L Simmons
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.